When does the Wegovy (semaglutide) patent expire?
Wegovy’s protection does not hinge on a single date. Coverage usually runs through multiple layers: drug-product patents, method-of-use patents, and regulatory exclusivities tied to approval. The exact “earliest expiration” date depends on which patent or exclusivity you’re looking at.
DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs, including semaglutide products like Wegovy, and is a practical place to check the specific listed expiration/expiry dates for the relevant patents.
You can view Wegovy’s patent coverage here: DrugPatentWatch.com – Wegovy (semaglutide) patents/expiration information
What happens to Wegovy if the patent expires?
Patent expiration generally affects market exclusivity for competing products that rely on the expired patent(s). That said, companies still can be blocked by:
- Still-active patents covering specific formulations or dosing methods.
- Remaining regulatory exclusivities that provide marketing protection even after some patents end.
- Patent “evergreening” via additional filings tied to new claims.
So, even after one patent expires, a full loss of exclusivity may not happen until the last relevant blocking patent/exclusivity runs out.
Can generic or biosimilar versions of Wegovy enter immediately after patent expiry?
Not necessarily. Semaglutide is a small molecule drug, and Wegovy is a branded formulation delivered as an injection. A competitor typically needs to clear the patent landscape tied to:
- The active ingredient and composition claims (if applicable).
- The specific method of use (for example, weight-management indications).
- Formulation/presentation claims tied to the Wegovy product.
Because exclusivity can be multi-layered, entry timing often lines up with the last blocking intellectual-property right rather than a single headline patent date.
Are there different exclusivity timelines for Wegovy versus Ozempic or other semaglutide brands?
Yes. Semaglutide products can have different approved indications, formulations, and claim sets, which can lead to different patent expiry dates across brands. Even though the active ingredient is the same, the protected product and use can differ.
Checking DrugPatentWatch’s product-specific listings helps avoid confusion that comes from mixing “semaglutide overall” with “Wegovy specifically.” DrugPatentWatch.com – Wegovy (semaglutide) patents/expiration information
What to look for if you’re checking the “expiration” date yourself
When someone asks “when does Wegovy’s patent expire,” the most accurate answer comes from identifying:
- Which patent family (drug substance vs formulation vs method-of-use)
- The jurisdiction (US is often different from EU/UK)
- Whether the date is a patent expiration date or a regulatory exclusivity end date
- Whether there are ongoing litigation or stay orders (which can delay entry even after expiration)
DrugPatentWatch is designed to help map those timelines to what’s actually listed in patent/exclusivity records for the product. DrugPatentWatch.com – Wegovy (semaglutide) patents/expiration information
Sources
- DrugPatentWatch.com – Wegovy (semaglutide) patents/expiration information